Skip to main content

Table 1 Characteristics of coronary artery disease patients

From: Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease

Parameter

All

Mild CAD

Moderate-severe CAD

P value

(n =170)

(SSS ≤8, n = 88)

(SSS >8, n = 82)

Age (yr)

65.7 ± 13.6

64.0 ± 13.1

67.6 ± 13.9

0.09

Male gender (%)

115 (68%)

55 (63%)

50 (73%)

0.14

Body mass index (kg/m2)

24.9 ± 3.7

24.9 ± 3.5

24.9 ± 4.1

0.99

Waist (cm)

85 ± 11

86 ± 12

84 ± 11

0.41

Hypertension (%)

73 (43%)

36 (41%)

37 (45%)

0.58

Diabetes mellitus (%)

36 (21%)

14 (16%)

22 (27%)

0.08

Smoking (%)

43 (25%)

14 (16%)

29 (35%)

0.004

LVEF

0.61 ± 0.16

0.68 ± 0.13

0.53 ± 0.16

< 0.0001

Creatinine (mg/dL)

1.13 ± 0.45

1.03 ± 0.34

1.22 ± 0.53

0.005

Fasting glucose (mg/dL)

116 ± 45

110 ± 42

123 ± 47

0.07

Total cholesterol (mg/dL)

186 ± 47

184 ± 38

189 ± 57

0.58

HDL-C (mg/dL)

48 ± 16

51 ± 18

44 ± 12

0.006

LDL-C (mg/dL)

108 ± 34

105 ± 26

111 ± 41

0.25

ALT (U/L)

29 ± 19

27 ± 19

30 ± 20

0.18

hsCRP (ug/mL)*

2.3 (1.1, 8.2)

1.8 (0.6, 4.6)

3.0 (1.7, 11.9)

0.0005

NT-proBNP (ng/L)*

107 (42, 797)

63 (38, 127)

797 (129, 2572)

< 0.0001

Adiponectin (mg/L)*

7.6 (5.2, 12.3)

7.4 (5.0, 10.0)

7.7 (5.3, 15.7)

0.13

A-FABP (ng/mL)*

26.2 (17.2, 40.1)

21.1 (16.2, 33.8)

32.4 (19.7, 48.5)

0.002

Medications

    

 ACEi/ARBs 

101 (59%)

34 (39%)

67 (82%)

< 0.0001

 Beta-blockers 

57 (34%)

23 (26%)

34 (41%)

0.03

 CCBs 

39 (23%)

24 (27%)

15 (18%)

0.16

 Diuretics 

51 (30%)

14 (16%)

37 (45%)

< 0.0001

 Statins 

36 (21%)

12 (14%)

24 (29%)

0.01

 Metformin 

12 (7%)

5 (6%)

7 (9%)

0.47

  1. Values are expressed as mean ± S.D., median (25th - 75th percentile), or n (percentage).
  2. *Logarithmically transformed before analysis.
  3. ACEi/ARBs, angiotensin-converting enzyme inhibitor / angiotensin II receptor blockers; A-FABP, adipocyte fatty acid-binding protein, ALT, alanine aminotransferase; CCBs, calcium channel blockers; HDL-C, high-density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction.